KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precigen (PGEN) Receivables (2016 - 2025)

Historic Receivables for Precigen (PGEN) over the last 14 years, with Q3 2025 value amounting to $1.1 million.

  • Precigen's Receivables rose 5089.16% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 5089.16%. This contributed to the annual value of $1.2 million for FY2024, which is 2893.57% up from last year.
  • Per Precigen's latest filing, its Receivables stood at $1.1 million for Q3 2025, which was up 5089.16% from $571000.0 recorded in Q2 2025.
  • Precigen's Receivables' 5-year high stood at $26.0 million during Q2 2021, with a 5-year trough of $511000.0 in Q2 2024.
  • For the 5-year period, Precigen's Receivables averaged around $8.6 million, with its median value being $1.6 million (2023).
  • Per our database at Business Quant, Precigen's Receivables soared by 697643.1% in 2021 and then plummeted by 9645.29% in 2024.
  • Precigen's Receivables (Quarter) stood at $1.9 million in 2021, then skyrocketed by 623.86% to $13.8 million in 2022, then crashed by 88.59% to $1.6 million in 2023, then fell by 26.16% to $1.2 million in 2024, then fell by 5.42% to $1.1 million in 2025.
  • Its Receivables stands at $1.1 million for Q3 2025, versus $571000.0 for Q2 2025 and $1.1 million for Q1 2025.